[Anticancer proteins and drugs: structure, function, and design].
Jacquemin-Sablon
A
A
CNRS UMR 1772, Institut Gustave-Roussy, 94800 Villejuif.
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000737:chemistry / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D003593:Cytoplasm / Q000378:metabolism; D015195:Drug Design; D016326:Extracellular Matrix Proteins / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000502:physiology*; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy; D009518:New York; D019098:Telomerase / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology
D000964:Antimetabolites, Antineoplastic; D016326:Extracellular Matrix Proteins; D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53; D019098:Telomerase